Skip to content

mHealth for Psychosis Help-seeking

User-centered Design of a Mobile Health Intervention to Promote Help-seeking and Reduce Duration of Untreated Illness Among Young Adults With Early Psychosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05905601
Enrollment
60
Registered
2023-06-15
Start date
2023-06-15
Completion date
2024-07-03
Last updated
2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis

Keywords

Early psychosis, Psychosis risk, Duration of untreated psychosis

Brief summary

The proposed study research project aims to develop and test a mobile health intervention designed to improve the wellness of young people at risk for psychosis and facilitate users' engagement with treatment and thus reduce duration of untreated psychosis. This clinical trial will involve a remote pilot randomized controlled trial that will examine (1) the feasibility of the proposed research approach, (2) the acceptability and usability of the NORTH intervention as well as (3) the specific additive value of help-seeking support in the context of self-guided mHealth for early psychosis. The full intervention, which includes psychoeducational lessons, Cognitive-Behavior Therapy-based practices, a symptom tracking feature, and help-seeking resources will be compared to a Lite version that will include the lessons, practices, and tracking but exclude the help-seeking resources.

Interventions

BEHAVIORALNORTH Full

NORTH is a native mobile app that provides on-demand content to young adults at risk for psychosis to improve or maintain their well-being, coping skills, and healthy habits, knowledge of psychosis, and provide help-seeking resources.

BEHAVIORALNORTH Lite

NORTH Lite contains the same on-demand lessons, practices and tracking features found in the Full NORTH mobile application but does not include help-seeking resources.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* Elevated risk for psychosis that warrants further evaluation (a distress score \>= 20 on the Prodromal Questionnaire, Brief \[PQ-B\], per Savill et al., 2018; and a positive frequency average score \>= 1.47 on the Community Assessment of Psychic Experiences \[CAPE-P15\], per Jaya et al., 2021 and Bukenaite et al., 2017) and confirmation of symptoms consistent with online data collection checks (per Moritz et al., 2013) * Age 18-30 years old * Lives in the United States * Under five years since participant's first psychotic episode or awareness of symptom onset * Owns an iPhone * Unengaged in specialty mental health treatment, in which the participant has not done either of the following in the previous three months: (1) taken a prescribed antipsychotic medication, (2) attended regular (i.e. more than one session of) psychotherapy.

Exclusion criteria

* Failed to demonstrate understanding of study details in comprehension screening process. * Engaged in specialty mental health treatment in the previous three months, defined as the following: (1) taken a prescribed antipsychotic medication, OR (2) attended regular (i.e. more than one session of) psychotherapy. * Unengaged in treatment, but only as a result of having completed or graduated from a specialty mental health program.

Design outcomes

Primary

MeasureTime frameDescription
Change in Resilience / CopingBaseline, 6 weeks, 12 weeksThe Brief Resilience Scale (BRS) will be used to assess resiliency. The BRS is a self-report form that consists of six resiliency statements that participants agree or disagree with on a five-point scale (1 = Strongly disagree, 5 = Strongly agree). Scores are totaled as a mean, and thus range from 1 to 5, with higher scores indicating greater resilience.
Change in Treatment Seeking StepsBaseline, 6 weeks, 12 weeksTreatment seeking will be measured using the Measure to Assess Steps to Service (MASS). The MASS is a 17-item self-report assessment of steps taken towards the attainment of mental health treatment, including research, social support, and engagement with service provider steps. Each item is endorsed on a three-point Likert scale (0 = No, I have not done this, 1 = I have done this once or twice, 2 = I have done this multiple times). The MASS is scored by summing individual items with higher scores indicating greater levels of treatment-seeking actions (range from 0 to 34). Increases in MASS scores were intended as an outcome of the proposed study (i.e. encouraging help-seeking).
Change in Treatment-related Attitudes/Beliefs (Treatment Beliefs)Baseline, 6 weeks, 12 weeksHelp-Seeking Attitudes and Stigma will be measured primarily using the Endorsed and Anticipated Stigma Inventory (EASI). The full EASI is a 40-item self-reported questionnaire with subscales measuring beliefs about mental illness, beliefs about mental health treatment, beliefs about mental health treatment seeking, concerns about stigma from loved ones, and concerns about stigma from the workplace. The subscales are scored by summing the ratings from the eight individual items in each subscale (5-point scale with 1 = Strongly disagree, 5 = Strongly agree), with lower scores indicating less stigma, and more positive attitudes towards treatment and treatment-seeking. The Beliefs About Treatment Scale assesses individuals' beliefs about the efficacy and usefulness of mental health treatments. It is totaled as a sum, and thus scores range from 8 to 40 with higher scores indicating more stigmatizing attitudes toward treatment.
Change in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)Baseline, 6 weeks, 12 weeksHelp-Seeking Attitudes and Stigma will be measured primarily using the Endorsed and Anticipated Stigma Inventory (EASI). The full EASI is a 40-item self-reported questionnaire with subscales measuring beliefs about mental illness, beliefs about mental health treatment, beliefs about mental health treatment seeking, concerns about stigma from loved ones, and concerns about stigma from the workplace. The subscales are scored by summing the ratings from the eight individual items in each subscale (5-point scale with 1 = Strongly disagree, 5 = Strongly agree), with lower scores indicating less stigma, and more positive attitudes towards treatment and treatment-seeking. The Beliefs About Treatment Seeking assesses individuals' attitudes toward seeking mental health treatments. It is totaled as a sum, and thus scores range from 8 to 40 with higher scores indicating more stigmatizing attitudes toward treatment seeking.
Change in Internalized StigmaBaseline, 6 weeks, 12 weeksThe Internalized Stigma of Mental Health Inventory, Brief (ISMI-9) will provide additional insight into the strength of participants' internalized stigma of mental illness. The ISMI-9 is a nine-item self-report short form, where each item is rated on a four-point Likert scale (1 = Strongly disagree, 4 = Strongly agree), and totaled as a mean score. Thus scores range from 1 to 4 with higher scores indicating more severe internalization of mental illness stigma.
Change in Perceived Stress**Baseline, 6 weeks, 12 weeksPerceived stress will be measured using the Perceived Stress Questionnaire (PSQ), which is a 30-item, self-report questionnaire that examines the experience of stress independent of a specific and objective occasion. Items are endorsed on a four-point scale (1 = Almost never, 4 = Usually), and are summed for a total score (ranging from 30 to 120), with higher scores indicating higher levels of perceived stress. \*\*NOTE: At baseline, the version provided to participants included the version of the PSQ that instructing participants to report on the past year or two while 6-week and 12-week assessments ask participants to report on the previous month or so. While totals are still reported (as these still provide some information about intervention effects) these numbers should be interpreted with caution and in concert with other collected measures that include items about stress levels and coping with consistent reporting periods at all time points.

Secondary

MeasureTime frameDescription
Change in Symptoms (Positive)Baseline, 6 weeks, 12 weeksThe Community Assessment of Psychic Experiences (CAPE-42) will be used to assess positive, negative and depressive symptoms of psychosis. The CAPE-42 is a self-report, 42 two-part item assessment that measures both the frequency of experiencing symptoms (four-point scale, 1 = Never, 4 = Almost Always) as well as the distress level (four-point scale, 1 = Not Distressed, 4 = Very Distressed) associated with each endorsed symptom. The CAPE weighted score can be calculated by summing the frequency and distress item responses. The positive subscale is 20 items and is totaled as a mean response ranging from 2 to 8, with higher scores indicating more frequent and distressing positive symptoms.
Change in Symptoms (Negative)Baseline, 6 weeks, 12 weeksThe Community Assessment of Psychic Experiences (CAPE-42) will be used to assess positive, negative and depressive symptoms of psychosis. The CAPE-42 is a self-report, 42 two-part item assessment that measures both the frequency of experiencing symptoms (four-point scale, 1 = Never, 4 = Almost Always) as well as the distress level (four-point scale, 1 = Not Distressed, 4 = Very Distressed) associated with each endorsed symptom. The CAPE weighted score can be calculated by summing the frequency and distress item responses. The negative subscale is 14 items and is totaled as a mean response ranging from 2 to 8, with higher scores indicating more frequent and distressing negative symptoms.
Change in Symptoms (Depressive)Baseline, 6 weeks, 12 weeksThe Community Assessment of Psychic Experiences (CAPE-42) will be used to assess positive, negative and depressive symptoms of psychosis. The CAPE-42 is a self-report, 42 two-part item assessment that measures both the frequency of experiencing symptoms (four-point scale, 1 = Never, 4 = Almost Always) as well as the distress level (four-point scale, 1 = Not Distressed, 4 = Very Distressed) associated with each endorsed symptom. The CAPE weighted score can be calculated by summing the frequency and distress item responses. The depressive subscale is 8 items and is totaled as a mean response ranging from 2 to 8, with higher scores indicating more frequent and distressing depressive symptoms.
Change in RecoveryBaseline, 6 weeks, 12 weeksRecovery will be assessed using the Choice of Outcome in CBT for Psychoses, Short Form (CHOICE-SF). The CHOICE-SF is an 11-item self-report form developed to assess recovery-related goals for therapy. Participants rate themselves in different therapy-focused areas such as self-confidence or ways of dealing with everyday stress on a scale (0 = Worst, 10 = Best). Scores on the CHOICE-SF are totaled as mean score across all standard items, and thus range from 0 to 10 with higher scores reflecting improved recovery.
Change in FunctioningBaseline, 6 weeks, 12 weeksFunctioning will be measured using the Sheehan Disability Scale (SDS). The SDS is a short, five-item self-report form that assesses disability and functional impairment. The total score is the sum of three items measure to what extent symptoms have disrupted different aspects of daily life on a scale (0 = Not at all, 10 = Severely), thus the scale ranges from 0 to 30 with higher scores indicating greater functional impairment.
Intervention Acceptability / Usability6 weeksUsability/Acceptability will be assessed with a modified version of the System Usability Scale derived from our group's previous work developing mHealth interventions. This composite measure, which comprises 26 items based on four measures - the System Usability Scale, Post Study System Usability Scale, Technology Assessment Model Measurement Scales, and Usefulness, Satisfaction and Ease Questionnaire - assesses participants' experiences with the intervention during the study period (1 = Disagree, 2 = Neutral, 3 = Agree). While this measure is often interpreted qualitatively by item, we will also compare the overall score, which will comprise an average and thus range from 1 to 3, with higher scores reflecting higher acceptability and usability.

Countries

United States

Participant flow

Participants by arm

ArmCount
NORTH Full
Participants in the experimental arm will be provided access to the Full NORTH smartphone application designed to support young adults at risk for psychosis. They will also have access to the research team by phone for technical troubleshooting and support as necessary. NORTH: NORTH is a native mobile app that provides on-demand content to young adults at risk for psychosis to improve or maintain their well-being, coping skills, and healthy habits, knowledge of psychosis, and provide help-seeking resources.
30
NORTH Lite
Participants in the control arm will be provided access to the NORTH Lite smartphone application designed to support young adults at risk for psychosis. They will also have access to the research team by phone for technical troubleshooting and support as necessary. NORTH Lite: NORTH Lite contains the same on-demand lessons, practices and tracking features found in the Full NORTH mobile application but does not include help-seeking resources.
30
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up13

Baseline characteristics

CharacteristicNORTH LiteTotalNORTH Full
Age, Continuous22.23 years
STANDARD_DEVIATION 3.82
22.22 years
STANDARD_DEVIATION 3.85
22.20 years
STANDARD_DEVIATION 3.94
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants10 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
23 Participants50 Participants27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants8 Participants5 Participants
Race (NIH/OMB)
Black or African American
10 Participants14 Participants4 Participants
Race (NIH/OMB)
More than one race
2 Participants7 Participants5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
White
14 Participants28 Participants14 Participants
Sex: Female, Male
Female
22 Participants46 Participants24 Participants
Sex: Female, Male
Male
8 Participants14 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 30
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Change in Internalized Stigma

The Internalized Stigma of Mental Health Inventory, Brief (ISMI-9) will provide additional insight into the strength of participants' internalized stigma of mental illness. The ISMI-9 is a nine-item self-report short form, where each item is rated on a four-point Likert scale (1 = Strongly disagree, 4 = Strongly agree), and totaled as a mean score. Thus scores range from 1 to 4 with higher scores indicating more severe internalization of mental illness stigma.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants who completed fewer than half of the items on the scale are excluded.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Internalized StigmaBaseline2.34 score on a scaleStandard Deviation 0.5
NORTH FullChange in Internalized Stigma6 weeks2.29 score on a scaleStandard Deviation 0.59
NORTH FullChange in Internalized Stigma12 weeks2.26 score on a scaleStandard Deviation 0.5
NORTH LiteChange in Internalized StigmaBaseline2.35 score on a scaleStandard Deviation 0.4
NORTH LiteChange in Internalized Stigma6 weeks2.22 score on a scaleStandard Deviation 0.59
NORTH LiteChange in Internalized Stigma12 weeks2.24 score on a scaleStandard Deviation 0.58
Primary

Change in Perceived Stress**

Perceived stress will be measured using the Perceived Stress Questionnaire (PSQ), which is a 30-item, self-report questionnaire that examines the experience of stress independent of a specific and objective occasion. Items are endorsed on a four-point scale (1 = Almost never, 4 = Usually), and are summed for a total score (ranging from 30 to 120), with higher scores indicating higher levels of perceived stress. \*\*NOTE: At baseline, the version provided to participants included the version of the PSQ that instructing participants to report on the past year or two while 6-week and 12-week assessments ask participants to report on the previous month or so. While totals are still reported (as these still provide some information about intervention effects) these numbers should be interpreted with caution and in concert with other collected measures that include items about stress levels and coping with consistent reporting periods at all time points.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Perceived Stress**Baseline87.14 score on a scaleStandard Deviation 14.76
NORTH FullChange in Perceived Stress**6 weeks82.97 score on a scaleStandard Deviation 15.28
NORTH FullChange in Perceived Stress**12 weeks79.66 score on a scaleStandard Deviation 18.35
NORTH LiteChange in Perceived Stress**Baseline92.33 score on a scaleStandard Deviation 12.52
NORTH LiteChange in Perceived Stress**6 weeks89.36 score on a scaleStandard Deviation 12.13
NORTH LiteChange in Perceived Stress**12 weeks85.40 score on a scaleStandard Deviation 14.7
Primary

Change in Resilience / Coping

The Brief Resilience Scale (BRS) will be used to assess resiliency. The BRS is a self-report form that consists of six resiliency statements that participants agree or disagree with on a five-point scale (1 = Strongly disagree, 5 = Strongly agree). Scores are totaled as a mean, and thus range from 1 to 5, with higher scores indicating greater resilience.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Resilience / CopingBaseline2.69 score on a scaleStandard Deviation 0.78
NORTH FullChange in Resilience / Coping6 weeks2.70 score on a scaleStandard Deviation 0.72
NORTH FullChange in Resilience / Coping12 weeks2.74 score on a scaleStandard Deviation 0.73
NORTH LiteChange in Resilience / CopingBaseline2.63 score on a scaleStandard Deviation 0.95
NORTH LiteChange in Resilience / Coping6 weeks2.82 score on a scaleStandard Deviation 1.01
NORTH LiteChange in Resilience / Coping12 weeks2.92 score on a scaleStandard Deviation 1.04
Primary

Change in Treatment-related Attitudes/Beliefs (Treatment Beliefs)

Help-Seeking Attitudes and Stigma will be measured primarily using the Endorsed and Anticipated Stigma Inventory (EASI). The full EASI is a 40-item self-reported questionnaire with subscales measuring beliefs about mental illness, beliefs about mental health treatment, beliefs about mental health treatment seeking, concerns about stigma from loved ones, and concerns about stigma from the workplace. The subscales are scored by summing the ratings from the eight individual items in each subscale (5-point scale with 1 = Strongly disagree, 5 = Strongly agree), with lower scores indicating less stigma, and more positive attitudes towards treatment and treatment-seeking. The Beliefs About Treatment Scale assesses individuals' beliefs about the efficacy and usefulness of mental health treatments. It is totaled as a sum, and thus scores range from 8 to 40 with higher scores indicating more stigmatizing attitudes toward treatment.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Treatment-related Attitudes/Beliefs (Treatment Beliefs)12 weeks18.95 score on a scaleStandard Deviation 5.24
NORTH FullChange in Treatment-related Attitudes/Beliefs (Treatment Beliefs)Baseline20.16 score on a scaleStandard Deviation 4.87
NORTH FullChange in Treatment-related Attitudes/Beliefs (Treatment Beliefs)6 weeks19.14 score on a scaleStandard Deviation 4.82
NORTH LiteChange in Treatment-related Attitudes/Beliefs (Treatment Beliefs)Baseline18.47 score on a scaleStandard Deviation 5.43
NORTH LiteChange in Treatment-related Attitudes/Beliefs (Treatment Beliefs)6 weeks19.13 score on a scaleStandard Deviation 4.9
NORTH LiteChange in Treatment-related Attitudes/Beliefs (Treatment Beliefs)12 weeks17.78 score on a scaleStandard Deviation 6.55
Primary

Change in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)

Help-Seeking Attitudes and Stigma will be measured primarily using the Endorsed and Anticipated Stigma Inventory (EASI). The full EASI is a 40-item self-reported questionnaire with subscales measuring beliefs about mental illness, beliefs about mental health treatment, beliefs about mental health treatment seeking, concerns about stigma from loved ones, and concerns about stigma from the workplace. The subscales are scored by summing the ratings from the eight individual items in each subscale (5-point scale with 1 = Strongly disagree, 5 = Strongly agree), with lower scores indicating less stigma, and more positive attitudes towards treatment and treatment-seeking. The Beliefs About Treatment Seeking assesses individuals' attitudes toward seeking mental health treatments. It is totaled as a sum, and thus scores range from 8 to 40 with higher scores indicating more stigmatizing attitudes toward treatment seeking.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)Baseline22.47 score on a scaleStandard Deviation 4.87
NORTH FullChange in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)6 weeks22.17 score on a scaleStandard Deviation 6.08
NORTH FullChange in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)12 weeks21.55 score on a scaleStandard Deviation 6.12
NORTH LiteChange in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)Baseline21.50 score on a scaleStandard Deviation 5.71
NORTH LiteChange in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)6 weeks22.44 score on a scaleStandard Deviation 7.7
NORTH LiteChange in Treatment-related Attitudes/Beliefs (Treatment Seeking Attitudes)12 weeks21.26 score on a scaleStandard Deviation 8.51
Primary

Change in Treatment Seeking Steps

Treatment seeking will be measured using the Measure to Assess Steps to Service (MASS). The MASS is a 17-item self-report assessment of steps taken towards the attainment of mental health treatment, including research, social support, and engagement with service provider steps. Each item is endorsed on a three-point Likert scale (0 = No, I have not done this, 1 = I have done this once or twice, 2 = I have done this multiple times). The MASS is scored by summing individual items with higher scores indicating greater levels of treatment-seeking actions (range from 0 to 34). Increases in MASS scores were intended as an outcome of the proposed study (i.e. encouraging help-seeking).

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Treatment Seeking StepsBaseline6.43 score on a scaleStandard Deviation 4.69
NORTH FullChange in Treatment Seeking Steps6 weeks7.65 score on a scaleStandard Deviation 5.18
NORTH FullChange in Treatment Seeking Steps12 weeks8.17 score on a scaleStandard Deviation 6.71
NORTH LiteChange in Treatment Seeking StepsBaseline10.08 score on a scaleStandard Deviation 7.08
NORTH LiteChange in Treatment Seeking Steps6 weeks9.58 score on a scaleStandard Deviation 7.33
NORTH LiteChange in Treatment Seeking Steps12 weeks9.49 score on a scaleStandard Deviation 8.09
Secondary

Change in Functioning

Functioning will be measured using the Sheehan Disability Scale (SDS). The SDS is a short, five-item self-report form that assesses disability and functional impairment. The total score is the sum of three items measure to what extent symptoms have disrupted different aspects of daily life on a scale (0 = Not at all, 10 = Severely), thus the scale ranges from 0 to 30 with higher scores indicating greater functional impairment.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Functioning12 weeks12.76 score on a scaleStandard Deviation 7.27
NORTH FullChange in FunctioningBaseline16.27 score on a scaleStandard Deviation 5.3
NORTH FullChange in Functioning6 weeks14.21 score on a scaleStandard Deviation 6.16
NORTH LiteChange in Functioning12 weeks14.31 score on a scaleStandard Deviation 7.57
NORTH LiteChange in FunctioningBaseline17.85 score on a scaleStandard Deviation 6.9
NORTH LiteChange in Functioning6 weeks14.65 score on a scaleStandard Deviation 7.64
Secondary

Change in Recovery

Recovery will be assessed using the Choice of Outcome in CBT for Psychoses, Short Form (CHOICE-SF). The CHOICE-SF is an 11-item self-report form developed to assess recovery-related goals for therapy. Participants rate themselves in different therapy-focused areas such as self-confidence or ways of dealing with everyday stress on a scale (0 = Worst, 10 = Best). Scores on the CHOICE-SF are totaled as mean score across all standard items, and thus range from 0 to 10 with higher scores reflecting improved recovery.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in RecoveryBaseline4.88 score on a scaleStandard Deviation 1.42
NORTH FullChange in Recovery6 weeks5.06 score on a scaleStandard Deviation 1.52
NORTH FullChange in Recovery12 weeks5.25 score on a scaleStandard Deviation 1.59
NORTH LiteChange in RecoveryBaseline4.77 score on a scaleStandard Deviation 1.96
NORTH LiteChange in Recovery6 weeks5.23 score on a scaleStandard Deviation 1.37
NORTH LiteChange in Recovery12 weeks5.54 score on a scaleStandard Deviation 1.74
Secondary

Change in Symptoms (Depressive)

The Community Assessment of Psychic Experiences (CAPE-42) will be used to assess positive, negative and depressive symptoms of psychosis. The CAPE-42 is a self-report, 42 two-part item assessment that measures both the frequency of experiencing symptoms (four-point scale, 1 = Never, 4 = Almost Always) as well as the distress level (four-point scale, 1 = Not Distressed, 4 = Very Distressed) associated with each endorsed symptom. The CAPE weighted score can be calculated by summing the frequency and distress item responses. The depressive subscale is 8 items and is totaled as a mean response ranging from 2 to 8, with higher scores indicating more frequent and distressing depressive symptoms.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Symptoms (Depressive)12 weeks4.47 score on a scaleStandard Deviation 1.4
NORTH FullChange in Symptoms (Depressive)Baseline4.90 score on a scaleStandard Deviation 1.2
NORTH FullChange in Symptoms (Depressive)6 weeks4.61 score on a scaleStandard Deviation 1.28
NORTH LiteChange in Symptoms (Depressive)12 weeks4.75 score on a scaleStandard Deviation 1.44
NORTH LiteChange in Symptoms (Depressive)Baseline5.32 score on a scaleStandard Deviation 1.1
NORTH LiteChange in Symptoms (Depressive)6 weeks4.61 score on a scaleStandard Deviation 1.29
Secondary

Change in Symptoms (Negative)

The Community Assessment of Psychic Experiences (CAPE-42) will be used to assess positive, negative and depressive symptoms of psychosis. The CAPE-42 is a self-report, 42 two-part item assessment that measures both the frequency of experiencing symptoms (four-point scale, 1 = Never, 4 = Almost Always) as well as the distress level (four-point scale, 1 = Not Distressed, 4 = Very Distressed) associated with each endorsed symptom. The CAPE weighted score can be calculated by summing the frequency and distress item responses. The negative subscale is 14 items and is totaled as a mean response ranging from 2 to 8, with higher scores indicating more frequent and distressing negative symptoms.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Symptoms (Negative)Baseline4.54 score on a scaleStandard Deviation 0.87
NORTH FullChange in Symptoms (Negative)6 weeks4.39 score on a scaleStandard Deviation 1
NORTH FullChange in Symptoms (Negative)12 weeks4.35 score on a scaleStandard Deviation 1.31
NORTH LiteChange in Symptoms (Negative)Baseline4.85 score on a scaleStandard Deviation 1.33
NORTH LiteChange in Symptoms (Negative)6 weeks4.38 score on a scaleStandard Deviation 1.1
NORTH LiteChange in Symptoms (Negative)12 weeks4.43 score on a scaleStandard Deviation 1.22
Secondary

Change in Symptoms (Positive)

The Community Assessment of Psychic Experiences (CAPE-42) will be used to assess positive, negative and depressive symptoms of psychosis. The CAPE-42 is a self-report, 42 two-part item assessment that measures both the frequency of experiencing symptoms (four-point scale, 1 = Never, 4 = Almost Always) as well as the distress level (four-point scale, 1 = Not Distressed, 4 = Very Distressed) associated with each endorsed symptom. The CAPE weighted score can be calculated by summing the frequency and distress item responses. The positive subscale is 20 items and is totaled as a mean response ranging from 2 to 8, with higher scores indicating more frequent and distressing positive symptoms.

Time frame: Baseline, 6 weeks, 12 weeks

Population: Participants are only analyzed (and total scores mean imputed) if they completed more than half the items on the scale.

ArmMeasureGroupValue (MEAN)Dispersion
NORTH FullChange in Symptoms (Positive)12 weeks3.18 score on a scaleStandard Deviation 0.99
NORTH FullChange in Symptoms (Positive)Baseline3.44 score on a scaleStandard Deviation 0.88
NORTH FullChange in Symptoms (Positive)6 weeks3.42 score on a scaleStandard Deviation 1.04
NORTH LiteChange in Symptoms (Positive)Baseline4.03 score on a scaleStandard Deviation 1.05
NORTH LiteChange in Symptoms (Positive)6 weeks3.68 score on a scaleStandard Deviation 1.15
NORTH LiteChange in Symptoms (Positive)12 weeks3.55 score on a scaleStandard Deviation 1.15
Secondary

Intervention Acceptability / Usability

Usability/Acceptability will be assessed with a modified version of the System Usability Scale derived from our group's previous work developing mHealth interventions. This composite measure, which comprises 26 items based on four measures - the System Usability Scale, Post Study System Usability Scale, Technology Assessment Model Measurement Scales, and Usefulness, Satisfaction and Ease Questionnaire - assesses participants' experiences with the intervention during the study period (1 = Disagree, 2 = Neutral, 3 = Agree). While this measure is often interpreted qualitatively by item, we will also compare the overall score, which will comprise an average and thus range from 1 to 3, with higher scores reflecting higher acceptability and usability.

Time frame: 6 weeks

Population: Participants are only analyzed if they completed more than half the items on the scale.

ArmMeasureValue (MEAN)Dispersion
NORTH FullIntervention Acceptability / Usability2.71 score on a scaleStandard Deviation 0.2
NORTH LiteIntervention Acceptability / Usability2.71 score on a scaleStandard Deviation 0.22

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026